• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-490-3p抑制肺腺癌的恶性进展。

MiR-490-3p Inhibits the Malignant Progression of Lung Adenocarcinoma.

作者信息

Li Zhiyong, Jiang Danfeng, Yang Sheng

机构信息

Department of Comprehensive Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.

Department of Day Care, Beijing Cancer Hospital, Beijing, People's Republic of China.

出版信息

Cancer Manag Res. 2020 Oct 30;12:10975-10984. doi: 10.2147/CMAR.S258182. eCollection 2020.

DOI:10.2147/CMAR.S258182
PMID:33154676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7608555/
Abstract

OBJECTIVE

To investigate the effects of miR-490-3p on the proliferation, migration, invasion and apoptosis of lung adenocarcinoma (LUAD) cells through the Wnt/β-catenin signaling pathway.

METHODS

Differentially expressed miRNAs in LUAD tissues were analyzed by bioinformatics and the target miRNA went through GSEA enrichment analysis. qRT-PCR was used to detect the expression of miR-490-3p in human LUAD cells and normal bronchial cells. The constructed vectors were transfected into the LUAD cell lines using Lipofectamine 2000. Cell viability was detected by MTT, cell migration and invasion were detected by transwell assay, and cell apoptosis was detected by flow cytometry. Western blot was performed to detect the expression levels of the proteins related to the Wnt/β-catenin pathway and cell apoptosis. Xenograft tumor mouse models were used for in vivo validation.

RESULTS

The results of qRT-PCR showed that miR-490-3p was relatively lowly expressed in LUAD cells, and the expression level was different in different LUAD cell lines. The results of MTT, transwell and flow cytometry exhibited that miR-490-3p could significantly inhibit the proliferation, migration, invasion and increase cell apoptosis rate of LUAD cells. Western blot results showed that miR-490-3p promoted the expression of Bax, Caspase-3 and E-cadherin as well as the phosphorylation of GSK-3β and inhibited the expression of Bcl-2, β-catenin and C-myc. Additionally, animal experiments were performed to prove that miR-490-3p suppressed LUAD malignant progression in vivo.

CONCLUSION

MiR-490-3p inhibited the proliferation, migration, invasion and promoted the apoptosis of LUAD cells by down-regulating the Wnt/β-catenin signaling pathway, suggesting that miR-490-3p may be an indicator for early diagnosis and prognosis of LUAD.

摘要

目的

通过Wnt/β-连环蛋白信号通路研究miR-490-3p对肺腺癌(LUAD)细胞增殖、迁移、侵袭和凋亡的影响。

方法

通过生物信息学分析LUAD组织中差异表达的miRNA,并对目标miRNA进行GSEA富集分析。采用qRT-PCR检测miR-490-3p在人LUAD细胞和正常支气管细胞中的表达。使用Lipofectamine 2000将构建的载体转染到LUAD细胞系中。通过MTT检测细胞活力,通过transwell实验检测细胞迁移和侵袭,通过流式细胞术检测细胞凋亡。进行蛋白质印迹法检测与Wnt/β-连环蛋白通路和细胞凋亡相关的蛋白质表达水平。采用异种移植瘤小鼠模型进行体内验证。

结果

qRT-PCR结果显示,miR-490-3p在LUAD细胞中表达相对较低,且在不同的LUAD细胞系中表达水平不同。MTT、transwell和流式细胞术结果表明,miR-490-3p可显著抑制LUAD细胞的增殖、迁移、侵袭并提高细胞凋亡率。蛋白质印迹法结果显示,miR-490-3p促进Bax、Caspase-3和E-钙黏蛋白的表达以及GSK-3β的磷酸化,并抑制Bcl-2、β-连环蛋白和C-myc的表达。此外,进行动物实验证明miR-490-3p在体内抑制LUAD的恶性进展。

结论

MiR-490-3p通过下调Wnt/β-连环蛋白信号通路抑制LUAD细胞的增殖、迁移、侵袭并促进其凋亡,提示miR-490-3p可能是LUAD早期诊断和预后的一个指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/e023ab1e2e02/CMAR-12-10975-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/87d726873231/CMAR-12-10975-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/e6e3e878e755/CMAR-12-10975-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/e445353293c1/CMAR-12-10975-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/313f66bbc5fb/CMAR-12-10975-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/e023ab1e2e02/CMAR-12-10975-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/87d726873231/CMAR-12-10975-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/e6e3e878e755/CMAR-12-10975-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/e445353293c1/CMAR-12-10975-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/313f66bbc5fb/CMAR-12-10975-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60a0/7608555/e023ab1e2e02/CMAR-12-10975-g0005.jpg

相似文献

1
MiR-490-3p Inhibits the Malignant Progression of Lung Adenocarcinoma.微小RNA-490-3p抑制肺腺癌的恶性进展。
Cancer Manag Res. 2020 Oct 30;12:10975-10984. doi: 10.2147/CMAR.S258182. eCollection 2020.
2
Effects of miR-330-3p on Invasion, Migration and EMT of Gastric Cancer Cells by Targeting PRRX1-Mediated Wnt/β-Catenin Signaling Pathway.miR-330-3p通过靶向PRRX1介导的Wnt/β-连环蛋白信号通路对胃癌细胞侵袭、迁移和上皮-间质转化的影响
Onco Targets Ther. 2020 Apr 22;13:3411-3423. doi: 10.2147/OTT.S238665. eCollection 2020.
3
Circ-AASDH functions as the progression of early stage lung adenocarcinoma by targeting miR-140-3p to activate E2F7 expression.环状AASDH通过靶向miR-140-3p激活E2F7表达,在早期肺腺癌进展中发挥作用。
Transl Lung Cancer Res. 2021 Jan;10(1):57-70. doi: 10.21037/tlcr-20-1062.
4
MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).microRNA-140-3p 通过靶向 TYMS(胸苷酸合成酶)抑制肺腺癌细胞的增殖、迁移、侵袭和血管生成。
Bioengineered. 2021 Dec;12(2):11959-11977. doi: 10.1080/21655979.2021.2009422.
5
MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.miR-340-3p-HUS1 轴抑制肺腺癌细胞的增殖和迁移。
Life Sci. 2021 Jun 1;274:119330. doi: 10.1016/j.lfs.2021.119330. Epub 2021 Mar 9.
6
CircRNA has_circ_0006427 suppresses the progression of lung adenocarcinoma by regulating miR-6783-3p/DKK1 axis and inactivating Wnt/β-catenin signaling pathway.环状 RNA 抑制肺腺癌的进展通过调节 miR-6783-3p/DKK1 轴和失活 Wnt/β-连环蛋白信号通路。
Biochem Biophys Res Commun. 2019 Jan 1;508(1):37-45. doi: 10.1016/j.bbrc.2018.11.079. Epub 2018 Nov 20.
7
CircRUNX1 drives the malignant phenotypes of lung adenocarcinoma through mediating the miR-5195-3p/HMGB3 network.环状RUNX1通过介导miR-5195-3p/HMGB3网络驱动肺腺癌的恶性表型。
Gen Thorac Cardiovasc Surg. 2024 Mar;72(3):164-175. doi: 10.1007/s11748-023-01960-5. Epub 2023 Jul 20.
8
Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.长链非编码 RNA HOTTIP 下调通过 HMGA2 介导的 Wnt/β-连环蛋白通路抑制口腔舌鳞癌细胞的增殖、迁移和侵袭。
Cancer Biother Radiopharm. 2020 Nov;35(9):720-730. doi: 10.1089/cbr.2019.3017. Epub 2020 Jan 8.
9
MiR-19a-3p regulates the Forkhead box F2-mediated Wnt/β-catenin signaling pathway and affects the biological functions of colorectal cancer cells.miR-19a-3p 通过调控叉头框 F2 介导的 Wnt/β-catenin 信号通路影响结直肠癌细胞的生物学功能。
World J Gastroenterol. 2020 Feb 14;26(6):627-644. doi: 10.3748/wjg.v26.i6.627.
10
MiR-202-3p inhibits the proliferation and metastasis of lung adenocarcinoma cells by targeting RRM2.微小RNA-202-3p通过靶向核糖核苷酸还原酶M2亚基抑制肺腺癌细胞的增殖和转移。
Ann Transl Med. 2022 Dec;10(24):1374. doi: 10.21037/atm-22-6089.

引用本文的文献

1
Inhibition of miR-9-3p facilitates ferroptosis by activating SAT1/p53 pathway in lung adenocarcinoma.抑制miR-9-3p通过激活肺腺癌中的SAT1/p53通路促进铁死亡。
Transl Lung Cancer Res. 2024 Dec 31;13(12):3426-3442. doi: 10.21037/tlcr-24-762. Epub 2024 Dec 27.
2
Connection between MiR-490 and CCND1 and GSK3β genes play an effective role in Wnt signaling pathway in colorectal cancer.miR-490 与 CCND1 和 GSK3β 基因的关系在结直肠癌的 Wnt 信号通路中起着重要作用。
Cell Biochem Biophys. 2024 Jun;82(2):1511-1521. doi: 10.1007/s12013-024-01304-x. Epub 2024 May 21.
3
Gene features of tumor-specific T cells relevant to immunotherapy, targeted therapy and chemotherapy in lung cancer.

本文引用的文献

1
[Differential expression of miR-126-5p in lung adenocarcinoma and the possible mechanism].[miR-126-5p在肺腺癌中的差异表达及可能机制]
Nan Fang Yi Ke Da Xue Xue Bao. 2019 Oct 30;39(10):1186-1190. doi: 10.12122/j.issn.1673-4254.2019.10.09.
2
MicroRNA-490-3p inhibits proliferation and stimulates apoptosis of ESCC cells via MAPK1 downregulation.微小RNA-490-3p通过下调丝裂原活化蛋白激酶1(MAPK1)抑制食管鳞状细胞癌(ESCC)细胞的增殖并促进其凋亡。
Oncol Lett. 2019 Sep;18(3):3170-3176. doi: 10.3892/ol.2019.10636. Epub 2019 Jul 18.
3
miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.
与肺癌免疫治疗、靶向治疗和化疗相关的肿瘤特异性T细胞的基因特征。
Heliyon. 2024 Mar 22;10(7):e28374. doi: 10.1016/j.heliyon.2024.e28374. eCollection 2024 Apr 15.
4
Long non-coding RNA CCAT1 acts as an oncogene to promote radiation resistance in lung adenocarcinoma: an epigenomics-based investigation.长链非编码 RNA CCAT1 作为癌基因促进肺腺癌的辐射抵抗:基于表观基因组学的研究。
Funct Integr Genomics. 2024 Mar 7;24(2):52. doi: 10.1007/s10142-024-01330-1.
5
BZW2 promotes malignant progression in lung adenocarcinoma through enhancing the ubiquitination and degradation of GSK3β.BZW2通过增强GSK3β的泛素化和降解促进肺腺癌的恶性进展。
Cell Death Discov. 2024 Feb 29;10(1):105. doi: 10.1038/s41420-024-01879-7.
6
GATA6 Suppresses Lung Adenocarcinoma Progression by Activating CFTR to Modulate Arachidonic Acid Metabolism.GATA6通过激活CFTR调节花生四烯酸代谢来抑制肺腺癌进展。
Comb Chem High Throughput Screen. 2025;28(4):582-591. doi: 10.2174/0113862073269158240122072743.
7
MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review).微小 RNA 在肺腺癌中的调控作用:信号通路与潜在治疗意义(综述)。
Oncol Rep. 2023 Dec;50(6). doi: 10.3892/or.2023.8648. Epub 2023 Oct 20.
8
Non‑coding RNAs: Role of miRNAs and lncRNAs in the regulation of autophagy in hepatocellular carcinoma (Review).非编码 RNA:miRNA 和 lncRNA 在调控肝癌自噬中的作用(综述)。
Oncol Rep. 2023 Jun;49(6). doi: 10.3892/or.2023.8550. Epub 2023 Apr 21.
9
High level of LncRNA MAPKAPK5-AS1 predicts poor prognosis and contributes to the malignant proliferation and EMT of non-small cell lung cancer via sponging miR-490-3p from HMGB2.LncRNA MAPKAPK5-AS1 高表达预示着非小细胞肺癌不良预后,通过海绵吸附 HMGB2 来源的 miR-490-3p 促进非小细胞肺癌恶性增殖和 EMT。
Genes Genomics. 2023 May;45(5):611-625. doi: 10.1007/s13258-022-01339-5. Epub 2022 Nov 29.
10
Identification of the circRNA-miRNA-mRNA Prognostic Regulatory Network in Lung Adenocarcinoma.肺腺癌中 circRNA-miRNA-mRNA 预后调控网络的鉴定。
Genes (Basel). 2022 May 16;13(5):885. doi: 10.3390/genes13050885.
miR-490-3p 通过调控组蛋白去乙酰化酶 2 来调节前列腺癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):539-546. doi: 10.26355/eurrev_201901_16866.
4
MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma.miR-490-3p 通过靶向 ATG7 抑制肝癌中的自噬。
IUBMB Life. 2018 Jun;70(6):468-478. doi: 10.1002/iub.1715. Epub 2018 Apr 20.
5
Cell death-based treatment of lung adenocarcinoma.基于细胞死亡的肺腺癌治疗方法。
Cell Death Dis. 2018 Jan 25;9(2):117. doi: 10.1038/s41419-017-0063-y.
6
miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.miRomics 和蛋白质组学揭示了 miR-296-3p/PRKCA/FAK/Ras/c-Myc 反馈环受肺腺癌中 HDGF/DDX5/β-catenin 复合物调控。
Clin Cancer Res. 2017 Oct 15;23(20):6336-6350. doi: 10.1158/1078-0432.CCR-16-2813. Epub 2017 Jul 27.
7
Non-small cell lung cancer: current treatment and future advances.非小细胞肺癌:当前治疗与未来进展。
Transl Lung Cancer Res. 2016 Jun;5(3):288-300. doi: 10.21037/tlcr.2016.06.07.
8
MiR-485 inhibits metastasis and EMT of lung adenocarcinoma by targeting Flot2.微小RNA-485通过靶向 flotillin-2抑制肺腺癌的转移和上皮-间质转化
Biochem Biophys Res Commun. 2016 Sep 2;477(4):521-526. doi: 10.1016/j.bbrc.2016.04.043. Epub 2016 Jun 1.
9
Cancer treatment and survivorship statistics, 2016.癌症治疗和生存统计,2016 年。
CA Cancer J Clin. 2016 Jul;66(4):271-89. doi: 10.3322/caac.21349. Epub 2016 Jun 2.
10
World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015.《2014年世界癌症报告》。瑞士日内瓦:世界卫生组织、国际癌症研究机构,世卫组织出版社,2015年。
Adv Nutr. 2016 Mar 15;7(2):418-9. doi: 10.3945/an.116.012211. Print 2016 Mar.